Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Meso-zeaxanthin.
A xanthophyll carotenoid that selectively accumulates in the macula lutea, providing photoprotection against high-energy blue light and neutralizing reactive oxygen species to maintain retinal integrity.
5281243
568.9 g/mol
11
(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Meso-zeaxanthin across standard consumer modalities.
Requires an oil-based carrier or beadlet technology to prevent oxidative degradation and ensure adequate bioavailability of the lipophilic molecule.
High susceptibility to thermal degradation during the pectin setting process and potential for uneven distribution within the hydrocolloid matrix.
Significant payload limitations due to the high dosage required for clinical efficacy and the challenge of stabilizing the carotenoid against photo-oxidation in a thin-film format.
Ready to launch a product featuring Meso-zeaxanthin? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Meso-zeaxanthin extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Meso-zeaxanthin payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation